MedPath

SATIN WP4 Acute Effect on Appetite of Pineapple Juice With Viscofiber and Red Ginseng

Not Applicable
Completed
Conditions
Healthy
Registration Number
NCT02396615
Lead Sponsor
University of Copenhagen
Brief Summary

The objective of the study is to establish whether a Pineapple juice with Viscofiber and Red ginseng can enhance satiety and reduce appetite and/or accelerate satiation in the short-term.

Detailed Description

A double-blind, randomised crossover design will be employed with an experimental (active) condition and a control condition at least one week apart. After having successfully completed screening procedures eligible participants will be invited for two separate test days, at least 7 days apart. On the two test days, the products will be provided in a randomized order as part of a fixed breakfast meal, and subjective appetite ratings will be measured every 30 min for the following 8 hours. Satiety and satiation will be measured through administration of test meals in the laboratory supplied with controlled food intake under free-living conditions

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Participants who have provided written informed consent
  • Healthy men and women
  • Ages between 18 and 55 years
  • BMI between 25.0-31.9 kg/m2
  • Regular breakfast eaters (eating breakfast ≥ 4 times a week)
  • Regular menstrual periods (women only)
Exclusion Criteria
  • Significant health problems as judged by the investigator
  • Taking any medication or supplements known to affect appetite or body weight within the past month and/or during the study as judged by the investigator
  • Pregnant, planning to become pregnant within the next 4 weeks or breastfeeding (women only)
  • History of anaphylaxis to food
  • Any known food allergies or food intolerance
  • Smoking, smoking cessation within the past 3 months or nicotine use (electronic cigarettes)
  • Self-reporting currently dieting or having lost/gained significant amount of weight (±3 kg) in the previous 3 months
  • Significant changes in physical activity patterns in the past 4 weeks or intention to change during the study as judged by the investigator
  • Significant change in diet in the past 4 weeks or intention to change the diet during the study as judged by the investigator
  • Use of systemic or local treatment likely to interfere with evaluation of the study parameters as judged by the investigator
  • Participants who work in appetite or feeding related areas
  • Participants not able to comply with the study protocol
  • Post-menopausal (women only)

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Ad libitum energy intakeTest day 2 (week 1)

Total ad libitum energy intake during test day 2

Secondary Outcome Measures
NameTimeMethod
VAS score for appetite sensation - hungerEvery 30 min during test day 1 and test day 2

Perceptions of hunger, assessed using 100 mm VAS scales

Eating behaviour questionnaire - three factor eating questionnairescreening

Three Factor Eating Questionnaire by Stunkard and Messick, 1985

VAS score for appetite sensation - prospective consumptionevery 30 min during test day 1 and test day 2

Perceptions of prospective suncumption, assessed using 100 mm VAS scales

Eating behaviour questionnaire - binge eating scaleScreening

Questionnaire by Gormally et al. 1982

Eating behaviour questionnaire - Control of Eatingscreening

Questionnaire by Hill et al. 1991

Eating behaviour questionnaire- power of foodscreening

Power of food scale by Lowe et al 2009

VAS score for appetite sensation - Desire to eatevery 30 min during test day 1 and test day 2

Perceptions of Desire to eat, assessed using 100 mm VAS scales

VAS score for appetite sensation - fullnessevery 30 min during test day 1 and test day 2

Perceptions of fullness, assessed using 100 mm VAS scales

Trial Locations

Locations (1)

University of Copenhagen

🇩🇰

Copenhagen, Frederiksberg, Denmark

University of Copenhagen
🇩🇰Copenhagen, Frederiksberg, Denmark

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.